从细胞疗效解离溶液中的DNA结合:癌细胞中印罗[3,2-b]类的结构分布关系
Maria João Álvaro-Martins1, Sandra N Pinto2, Bárbara Bahls3
1Centro de Química Estrutural, Institute of Molecular Sciences, Departamento de Engenharia Química, Instituto Superior Técnico, Universidade de Lisboa, 1049-001 Lisboa, Portugal.
Bioorganic chemistry
|February 19, 2026
概括
优化抗癌药物需要了解它们如何进入细胞. 这项研究表明,较少的脂性印罗基诺林更好地准癌细胞核,通过改善细胞分布来增强其抗癌活性.
科学领域:
- 药用化学 医学化学
- 分子药理学分子药理学
- 癌症治疗方法 癌症治疗方法
背景情况:
- 了解小分子DNA结合剂在细胞中的分布,是设计有效抗癌剂的关键.
- 结构-分布关系对于亚细胞局部化和抗癌活性至关重要.
研究的目的:
- 阐明控制癌细胞中印罗基诺林局部化和抗癌活性的结构分布关系.
- 调查脂性对核向和抗扩散功能的影响.
主要方法:
- 对四种印罗基诺林衍生物的系统分析.
- 双光子光显微镜用于亚细胞局部化.
- DNA 相互作用和抗增殖性试验 (IC50).
- 在生理学pH值下对脂性评估 (LogD7.4)
主要成果:
- 一种带有长胺侧链的单衍生物 (6) 由于较低的脂友性 (LogD7.4 = 0.6) 显示出优越的核向和效力 (IC50: 1.82.4 μM).
- 在细胞质中积累了具有较高脂性 (LogD7.4 ≥3.2) 的二化类似物,显示出较低的抗增殖活性.
- 在溶液中的DNA结合亲和力和细胞内DNA向功效之间存在脱节.
结论:
- 核积累对于强大的细胞毒性至关重要,由pH依赖的脂性决定,受化和侧链长度的影响.
- 对于设计有效的DNA向性抗癌剂而言,较少的脂性印罗基诺林是优先考虑的.
- 结果解决了结构-活性关系的差异,并为优化化疗药物提供了战略.
相关概念视频
DNA Topoisomerases
36.1K
Topoisomerases are enzymes that relax overwound DNA molecules during various cell processes, including DNA replication and transcription. These enzymes regulate positive and negative DNA supercoiling without changing the nucleotide sequence. DNA overwinding in a clockwise direction results in positively supercoiled DNA, whereas underwinding in a counterclockwise direction produces negatively supercoiled DNA.
Types and Mechanism of action
Topoisomerases are divided into two main types. ...
Types and Mechanism of action
Topoisomerases are divided into two main types. ...
36.1K
Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Drugs that Destabilize Microtubules
4.1K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
4.1K
Inhibition of Cdk Activity
6.1K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
DNA Helicases
24.3K
DNA unwinding helicase enzymes are a type of motor protein. Motor proteins can translocate along filaments or polymers using energy generated from ATP hydrolysis. Helicases are involved in all the important cellular processes where DNA unwinding is required, such as DNA replication, repair, recombination, and transcription. They are present in all living organisms, but vary in their structure, function, and mechanism of action. For example, in prokaryotes, DnaB helicase binds and translocates...
24.3K
Drugs that Stabilize Microtubules
2.8K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.8K


